The ATF7 proteins, which are members of the cyclic AMP responsive binding protein (CREB)/activating transcription factor (ATF) family of transcription factors, display quite versatile properties: they can interact with the adenovirus E1a oncoprotein, mediating part of its transcriptional activity; they heterodimerize with the Jun, Fos or related transcription factors, likely modulating their DNA-binding specificity; they also recruit to the promoter a stress-induced protein kinase (JNK2). In the present study, we investigate the functional relationships of ATF7 with hsTAF12 (formerly hsTAF II 20/15), which has originally been identified as a component of the general transcription factor TFIID. We show that overexpression of hsTAF12 potentiates ATF7-induced transcriptional activation through direct interaction with ATF7, suggesting that TAF12 is a functional partner of ATF7. In support of this conclusion, chromatin immunoprecipitation experiments confirm the interaction of ATF7 with TAF12 on an ATF7-responsive promoter, in the absence of any artificial overexpression of both proteins. We also show that the TAF12-dependent transcriptional activation is competitively inhibited by TAF4. Although both TAF12 isoforms (TAF12-1 and -2, formerly TAF II 20 and TAF II 15) interact with the ATF7 activation region through their histone-fold domain, only the largest, hsTAF12-1, mediates transcriptional activation through its N-terminal region.
Introduction
The family of activating transcription factor (ATF)7 1 (formerly ATFa) transcription factors, structurally and functionally related to the ATF2 family, is composed of at least three members (ATF7-1, 2, 3) (Gaire et al., 1990; Chatton et al., 1993) , translated from alternatively spliced messengers issued from a single gene . Although the three ATF7 isoforms only differ by the presence of small motifs of 11 and 21 residues within their N-terminal region, they exhibit indistinguishable activities. Their transcriptional activation domain has been delineated within the N-terminal part of the protein and shown to comprise an essential zinc-binding element and two conserved threonine residues (T51 and T53, corresponding to the T69 and T71 homologues in ATF2) (Chatton et al., 1994) . This region, together with sequences located in the Cterminal portion of the ATF7 proteins, contributes to their interaction with the adenovirus E1a oncoprotein (Chatton et al., 1993) . ATF7, like ATF2, can also associate with c-Jun or c-Fos proteins through their C-terminal leucine-zipper (b-LZ) region. While ATF proteins usually bind as dimers to ATF/cyclic AMP responsive binding (CRE) promoter elements, they also bind TRE sequences if heterodimerized with members of the Jun family (Ivashkiv et al., 1990; Chatton et al., 1994; Chatton et al., 1995) . Finally, the ATF7 proteins strongly interact with the JNK2 protein kinase (Bocco et al., 1996) . However, they do not constitute substrates for this kinase but rather serve as a JNK2-docking site for ATF7-associated partners like JunD (De Graeve et al., 1999) , thus likely playing important functions, early in cell signalling.
The RNA polymerase II transcription factor TFIID (transcription factor IID) is a multiprotein complex composed of the TATA-binding protein (TBP) and a series of TBP-associated factors (TAFs) (Bell and Tora, 1999; Albright and Tjian, 2000; . Distinct subsets of human (hs) TAFs are also components of the TFIID-related SAGA (SPT-ADA-GCN5-acetyltransferase), STAGA (SPT3-TAF9-GCN5-L acetyltransferase), PCAF (p300/CREB-binding protein-associated factor), and TFTC (TBP-free TAF-containing complex) complexes (for a review, see Martinez, 2002; Timmers and Tora, 2005) . The recently proposed RNA polymerase II TAF nomenclature will be used in the following.
Several reports revealed that specific TFIID subunits (TAF1, 2, 5 and10) are important for the regulation of cell cycle and apoptosis (for a review, see Martinez, 2002) . Genetic studies in Saccharomyces (Bhaumik and Green, 2002; Mencia et al., 2002; Shen et al., 2003) , Drosophila (Pham et al., 1999) , Caenorhabditis (Walker et al., 2001) and mouse (Freiman et al., 2001) indicated that particular combinations of TAFs are mobilized in response to different growth stimuli. Demonstration that some TAFs act as specific coactivators has emerged from investigations on the role of hsTAF11 (Mengus et al., 2000) , hsTAF10 (Jacq et al., 1994) , hsTAF4 and hsTAF7 (Munz et al., 2003) . Furthermore, studies on the cyclin A gene promoter revealed that the upstream binding element for the ATF protein is hsTAF1-responsive (Wang et al., 1997) , suggesting a functional connection between ATF variants and hsTAFs.
The molecular structure of TAFs has been remarkably well conserved throughout evolution (Hoffmann et al., 1997; Gangloff et al., 2001; Martinez, 2002) . Specific histone-fold domains (HFDs) have been described to play a critical role in the structural organization of several TAFs. Sequence comparisons and structural studies revealed that TAF6 and TAF9 contain HFDs, which are similar to those of core histones H3 and H4 and interact to form an H3-H4-like heterotetramer Xie et al., 1996) . In addition, hsTAF4 and hsTAF12 interact via HFDs similar to those of H2A and H2B, respectively . Within TFIID, these two tetramers likely associate to form an octamer-like substructure, potentially facilitating the binding of TFIID to core promoters, within chromatin (Hoffmann et al., 1997) .
In the present study, we show that hsTAF12 mediates the transcriptional activity of ATF7 through direct interactions between the two factors, implicating the N-terminal domains of ATF7 and hsTAF12, as well as the latter's HFD. TAF4, but not TAF4b, specifically inhibits this transactivation.
Results

ATF7-induced transactivation is mediated by hsTAF12
To get an insight into the mechanism of the transcriptional activation achieved by ATF7, we investigated the potential interplay of this protein with components of the basal transcription machinery. We first examined the influence of different hsTAFs on the transcriptional properties of ATF7. To circumvent major interferences with endogenous ATF and TBP proteins, the Gal4 protein fusion system (Liu and Green, 1990) was used, in which the ATF7-1 protein was linked to the yeast Gal4 DNA-binding domain (1-147). The activity of the chimeric product (pG4-ATF7, Figure 1 ) was assayed in cotransfection experiments with a luciferase reporter gene whose promoter contained five Gal4-binding sites and a TGTA motif in place of the original TATA element. Cos-1 cells were transfected with the following recombinant plasmids: (i) the pG4-ATF7 vector, (ii) a vector encoding a TBP mutant (TBP-spm3) that selectively recognizes the TGTA derivative of the TATA box (Lavigne et al., 1999) , (iii) the luciferase reporter and (iv) a vector expressing each of the hsTAFs tested or the corresponding empty vector. The results of a typical experiment are shown in Figure 1 .
Under conditions where equal levels of G4-ATF7-1 and the different hsTAFs tested were expressed, as verified by immunoblotting with specific antibodies (not shown), coexpression of hsTAF12 had the strongest effect among all hsTAFs tested, with a nearly fivefold stimulation of G4-ATF7 transcriptional activity, in the absence of TBP-spm3 (compare lanes 1 and 21). As expected, the stimulation was highest in the presence of TBP-spm3 (compare lanes 2 and 22), reaching a level of about 10-fold. Identical results were obtained with the three ATF7 isomers, namely ATF7-1, ATF7-2 and ATF7-3 (not shown), clearly indicating that, under these experimental conditions, hsTAF12 plays a pivotal role in the ATF7-induced transactivation process.
We then asked if this hsTAF12-mediated transcriptional activation was specific of the family of ATF factors by testing the effect of hsTAF12 on the activity of other Gal4-fused activators, like the ATF2 factor, functionally related to ATF7 (Maekawa et al., 1989) , or c-Jun, a b-LZ protein that heterodimerizes with and activates ATF7/ATF2. As expected, reporter activity was stimulated by G4-ATF2 to the same extent as G4-ATF7, in the presence of TAF12 (Figure 2, lanes 1, 2) . By contrast, under the same conditions, G4-cJun did not significantly induce reporter expression (Figure 2, lanes 19, 20) . Together, these results emphasize the specific implication of hsTAF12 in the transcriptional activation by the ATF7/ATF2 protein family, as observed in our assay. The N-terminal domain of ATF7 is essential for hsTAF12-mediated activation To further examine the role of hsTAF12 in this activation process, we analysed its effect on various derivatives of the G4-ATF7 construction (Figure 2a) . The full-length ATF7 proteins, which exhibit only marginal transcriptional activity (Chatton et al., 1993) , are stimulated about 10-fold in the presence of hsTAF12 (Figure 1 ). Deletion of amino-acid residues from the Nterminal end of the ATF7 moiety [DN (1-296)] severely reduced the activity (Figure 2b , lane 6), in accordance with this region exhibiting activation function (De Graeve et al., 1999) . By contrast, ablation of the Cterminal half of ATF7 ] resulted in a roughly 10-fold further stimulation (Figure 2b , lane 10). The higher activity of this latter ATF7 deletion mutant reflected the unmasking of the ATF7 activation domain resulting from the elimination of the entire DNAbinding domain, previously suspected to hinder ATF7 intrinsic activity (Chatton et al., 1994) . Removal of only 120 residues ] had indeed no effect on the activity of the protein (Figure 2b, lane 8) . We therefore decided to analyse the effect of mutations specifically targeting the activation domain of ATF7, within either the C-terminally truncated (DC-C9A; DC-T51A, T53A) or the full-length ATF7 context (C9A; T51A, T53A). As shown in Figure 2b , using both constructs, mutations altering the zinc-binding element (lanes 12 and 16) or two critical phosphorylation sites (lanes 14 and 18), severely affected reporter stimulation by hsTAF12, in agreement with our earlier conclusion that the integrity of each of these elements, also conserved in ATF2, are crucial to the ATF7 activation function (De Graeve et al., 1999) .
Only the largest isoform of hsTAF12 mediates ATF7-induced transactivation Two isoforms of hsTAF12 are generated from the unique gene (Mengus et al., 1995; . Comparison of the relative abundance of these two forms by Western blotting (WB) revealed that the longer version (hsTAF12-1, formerly TAF20) was about five times more abundant than the shorter one (hsTAF12-2, formerly TAF15), in all cell types examined (Perletti et al., 1999) . Similarly, in cells transfected with a vector harbouring the full-length cDNA (p-hsTAF12wt; see Figure 3a ), hsTAF12-1 accumulated about 15 times more efficiently than hsTAF12-2 ( Figure 3b , lane 2). When the effect of transfecting this p-hsTAF12wt vector was compared, in our luciferase assay, with that of vectors (p-hsTAF12-1 and p-hsTAF12-2) expressing only the larger or shorter forms of TAF12, respectively, it became clear that hsTAF12-1 contributed to most of the stimulation of ATF7 activity (Figure 3b , compare lanes 2-4). These results indicate that the N-terminal 30 residues of hsTAF12 are predominantly involved in this activation process.
ATF7 and hsTAF12 interact in vivo
We next examined the ability of ATF7 and hsTAF12 to associate within a cellular context. To this end, cells were transfected with plasmids expressing either phsTAF12wt (coding for the two forms) or p-hsTAF12-2, together with px-ATF7 (Figure 3c ). Whole-cell extracts were then submitted to immunoprecipitation (IP) with antibodies against ATF7 and the immune complexes were analysed by WB using anti-TAF12 antibodies. As shown in Figure 3c (lanes 1 and 2), although both TAF12 isoforms were equally expressed, hsTAF12-1 was predominantly detected in the immunoprecipitate. In agreement with the transcription results (Figure 3b ), this observation clearly confirms the major contribution of hsTAF12-1, with the first 30 residues of this protein playing an important role in its interaction with ATF7. Owing to the low level of endogenous ATF7 , we have not been able to conclusively reveal ATF7-TAF interactions, using nontransfected cell extracts. However, overexpression of ATF7 alone allowed the detection of TAF12 in IP experiments ( Figure 3d , lane 3), in accordance with the results above ( Figure 3c ).
We have also performed pull-down experiments with baculovirus-based vectors expressing a glutathione-Stransferase (GST)-ATF7 fusion protein and hsTAF12 protein. Our results ( Figure 3e , lane 2) revealed that TAF12 was carried along with the ATF7 fusion on glutathione-agarose beads, when assaying extracts from cells coinfected with both vectors. Since only a minor fraction of TAF12 was pulled-down by a nonfused GST protein ( Figure 3e , lane 4), these data also confirm the results of the co-IP experiments ( Figure 3c ). Furthermore, since the GST pull-down was carried out on late-infected cell extracts (i.e. under conditions where baculovirus-encoded proteins are in large excess over cellular proteins), we conclude that the interaction between ATF7 and TAF12 is likely to be direct and to involve no additional cellular partner.
Structural domains involved in the ATF7-hsTAF12 interplay
Although the ability of hsTAF12-1 to interact with ATF7 was highest, hsTAF12-2 exhibited a significant residual binding capacity (see Figure 3c ). As detailed in Figures 3 and 4a, both hsTAF12-1 and 2 contain a structural motif, known as the 'HFD', which resembles the H2B HFD and can heterodimerize with hsTAF4 to form a histone-like complex (Werten et al., 2002) . To examine whether this structural motif of hsTAF12 is implicated in the interaction with ATF7, the effect of mutations disrupting the critical a2 (m2) or a3 (m3) helical portions of this domain were tested on both interaction and transcriptional properties. Whereas mutation (m0), targeting a region located between helices a3 and aC affected neither transcriptional stimulation ( Figure 4b ) nor interaction (Figure 4c ), mutations (m2) and (m3) dramatically hampered both . Extracts (500 mg) from transfected cells were immunoprecipitated (IP) with the anti-ATF7 (2F10) monoclonal antibodies as described in Materials and methods. The immune complexes were separated by SDS-polyacrylamide gel electrophoresis (PAGE). Western blotting (WB) using specific antibodies revealed the presence of hsTAF12 proteins in both IP and extracts, and of ATF7 in the extracts. (d) Cos-1 cells were transfected with 0.5 mg px-ATF7, in the presence or absence of p-hsTAF12wt (2 mg), where indicated. Extracts (500 mg) from transfected cells were immunoprecipitated (IP) with the anti-ATF7 (2F10) monoclonal antibodies as described in Materials and methods. The immune complexes were separated by SDS-PAGE. Western-blotting (WB) using specific antibodies revealed the presence of hsTAF12 proteins in both IP and extracts, and of ATF7 in the extracts. (e) Sf9 cells were coinfected with two recombinant baculoviruses, one directing the expression of either GST-ATF7 or the GST moiety alone and the other directing the expression of hsTAF12. About 48 h postinfection, extracts were prepared and GST-pulldown assays were performed. Aliquots of the total extracts (Extracts) and the GST-bound fractions (GST-pulldown) were analysed by SDS-PAGE and proteins visualized by Western blotting (WB) using specific antibodies ATF7/TAF12 functional interaction P-J Hamard et al activities, under conditions where similar levels of ATF7 and hsTAF12 proteins were produced. These results indicate that, in addition to the N-terminal portion of hsTAF12-1, the HFD motif also contributes to the ATF7-induced transactivation process.
To delineate the region of ATF7 implicated in these interactions, hsTAF12 was submitted to IP analysis, in the presence of ATF7 or selected derivatives thereof. As shown in Figure 4d , the hsTAF12-1 protein was coprecipitated either with the wild-type ATF7 (lane1) or its C-terminally deleted version (lane 5). The efficiencies of these coprecipitations were in fact very similar if the levels of expressed ATF7 are adjusted in these lanes, ruling out any major contribution of the C-terminal part of ATF7 in its interaction with hsTAF12. By contrast, mutations altering the N-terminal activation domain of ATF7 (lanes 2-4) severely impaired the interaction between the two proteins. These results clearly indicate that the zinc-binding element and threonine residues 51 and 53, essential to the ATF7 activation function, are also involved in ATF7-hsTAF12 association.
The N-terminal domain of the largest hsTAF12 contains a motif found in Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinases (MAP kinases)
The MAP kinases p38 and JNK interact with specific docking site sequences ('D-sites'), on their respective target proteins (Chang et al., 2002; Ho et al., 2003) . As JNK2 also binds to ATF7 (De Graeve et al., 1999) , alignments were performed with ATF2, ATF7 and other JNK or p38 substrates. As shown in Figure 5a , the presence of a potential D-site was revealed within the ATF7 sequence. Moreover, since the same ATF7 residues are required for both TAF12-and JNK2-induced activities (present study and De Graeve et al., 1999), we also performed protein sequence alignments between TAF12 and MAP kinases. Interestingly, residues of the JNK and p38 kinases (collectively making up 'anti D-sites'), known to engage the D-site of their substrates (Chang et al., 2002) , were conserved within the N-terminal part of TAF12 (Figure 5a ). Mutations of some of these conserved . Mutants with sequences altered in the a2 (m2), a3 (m3) or last linker region (m0) are depicted. Numbers refer to the amino-acid coordinates in the wild-type (wt) hsTAF12-1 protein. (b) Graphic representation of luciferase assays (arbitrary units). Cos-1 cells were cotransfected with the luciferase reporter (2 mg), the pG4-ATF7 vector (0.25 mg) and the TBPspm3 (0.25 mg) vectors, together with either the p-hsTAF12wt (0.5 mg) expression vector or its mutated derivatives (m0-m3), as indicated. The results of luciferase assays are presented. The levels of hsTAF12 protein in extracts used for luciferase assays were determined by Western blotting. (c) Coimmunoprecipitation of hsTAF12 and ATF7. Cos-1 cells were transfected with 0.5 mg of px-ATF7, in combination with 2 mg of p-hsTAF12wt or corresponding m0, m2 and m3 derivatives, as indicated. Extracts (500 mg) were immunoprecipitated (IP) with the anti-ATF7 and assayed for the presence of hsTAF12 and ATF7 proteins, as in (c). (d) Cos-1 cells were transfected with p-hsTAF12wt and px-ATF7 or corresponding derivatives. Extracts (500 mg) from transfected cells were treated as in (c) and assayed for the presence of hsTAF12 and ATF7 proteins, as indicated. The asterisk refers to a nonspecific signal ATF7/TAF12 functional interaction P-J Hamard et al residues were generated within TAF12 and ATF7 and their effects in our transactivation assay examined. As shown in Figure 5b (compare lanes 5, 7, 9 with lane 3), mutations of the putative anti-D-site residues of TAF12 significantly affected reporter stimulation in our luciferase assay. The transactivation was severely reduced by mutations altering the ATF7 D-site (compare lanes 4, 6, 8, 10 with lane 3). These results clearly indicate that the regions of both TAF12 and ATF7 proteins, potentially involved in their mutual interaction or implicated in JNK docking onto ATF7, are important for their transcriptional activity.
TAF4 interferes with ATF7-TAF12-mediated transcriptional activation
Within TFIID, TAF12 is generally found associated with TAF4 . However, this partner may be replaced by TAF4b, a tissue-specific TAF4 paralog (Freiman et al., 2001) . Since both TAF4 and TAF4b have a potential interaction domain with the same region of TAF12 as that involved in TAF12-ATF7 interaction (Werten et al., 2002) , we tested the effect of an overproduction of these alternative TAFs on the ATF7-induced transactivation mediated by hsTAF12. As revealed in Figure 6a (lanes 2-4) , coexpression of TAF4 clearly inhibited TAF12-mediated transactivation by ATF7, while TAF4b had only a minor effect (lanes 5-7).
To gain some insight into the molecular mechanism of this differential action on transcription, we examined the ability of hsTAF12, TAF4 and TAF4b to associate with ATF7. To this end, cells were transfected with plasmids expressing TAF12wt together with ATF7 (Figure 6b) , in the absence (lane 1) or presence of increasing amounts of hemaglutinin (HA)-tagged TAF4b (lanes 2-4) or TAF4 (lanes 5-7). Cell extracts were then submitted to IP with antibodies against ATF7 and the immune complexes were analysed by WB.
As expected, hsTAF12 was coprecipitated with ATF7 when neither TAF4 nor TAF4b were overexpressed (Figure 6b, lane 1) . However, while coexpression of Figure 5 Role of the N-terminal region of TAF12 in mediating the ATF7 transcriptional activity. (a) Peptide sequence alignments between potential D-sites of JNK2 (accession #P45984), p38 (accession #Q16539), hsTAF12 (accession #Q16514) and derivatives, and potential anti-D-sites of MEF2A (accession #Q02078), MKK3b (accession #P46734), c-Jun (accession #P04512), ATF2 (accession #P15336), ATF7 (accession #P17544) and derivatives are shown. Conserved sequence elements are shaded. Numbers refer to aminoacid coordinates, relative to the starting methionine. (b) Graphic representation of luciferase assays (arbitrary units). Cos-1 cells were cotransfected with the luciferase reporter (2 mg), the TBPspm3 (0.25 mg) vector, 0.25 mg pG4-ATF7 or pG4-ATF7 (M33D, L35S) vectors, in the presence of 0.5 mg of p-hsTAF12wt or (L9D, L12R), (L12G, F15G), (I18G, E21R) derivatives, as indicated. The presence of hsTAF12 and ATF7 proteins in extracts was revealed by Western blotting (WB) using specific antibodies ATF7/TAF12 functional interaction P-J Hamard et al TAF4b had no effect (lanes 2 and 3), overexpression of TAF4 abolished TAF12-ATF7 interaction (lanes 5 and 6). Moreover, in contrast to TAF4b, TAF4 was present in the immunoprecipitate, whether expressed in the presence or absence of TAF12 (lanes 1-7) . GST pulldown experiments, using baculovirus expression vectors, confirmed that TAF4 was selectively pulled down along with the GST-ATF7 fusion protein (Figure 6c ). Together, these results not only demonstrate an interaction between ATF7 and TAF4 but also indicate, as in the case of TAF12 (see Figure 3e) , that no additional cellular component is required for this binding. They Figure 6 hsTAF4 inhibits ATF7 TAF12 interaction. (a) Cos-1 cells were cotransfected with the luciferase reporter (2 mg) the pG4-ATF7 vector (0.25 mg) and the TBPspm3 (0.25 mg) vectors, together with either the p-hsTAF12wt (0.5 mg) and increased amounts (0.5-1-2 mg) of p-hsTAF4wt (lanes 2-4) or p-hsTAF4bwt (lanes 5-7) vectors, where indicated. Graphic representation of luciferase assays (arbitrary units) is presented. (b) Cos-1 cells were transfected with 0.5 mg px-ATF7 and hsTAF12, together with increased amounts of p-hsTAF4bwt (0.2-2 mg; lanes 2-4) or p-hsTAF4wt (0.2-2 mg; lanes 5-7), where indicated. Extracts from transfected cells were immunoprecipitated (IP) with the anti-ATF7 (2F10) monoclonal antibodies as described in Materials and methods. The immune complexes were separated by SDS-PAGE. The presence of hsTAF12 and TAF4 proteins in both IP and extracts, and of hsTAF12, TAF4 and ATF7 in the extracts was revealed by Western blotting (WB) using specific antibodies. The presence of HA-tagged TAF4b in both IP and extracts (lanes 1-4) was revealed in both IP and extracts using anti-HA antibodies. (c) Sf9 cells were coinfected with two recombinant baculoviruses, one directing the expression of either GST-ATF7 or the GST moiety alone and the other directing the expression of hsTAF4. About 48 h postinfection, extracts were prepared and GST-pulldown assays were performed. Aliquots of the total extracts (Extracts) and the GST-bound fractions (GST-pulldown) were analysed by SDS-PAGE and proteins visualized by WB using specific antibodies ATF7/TAF12 functional interaction P-J Hamard et al also suggest that TAF4 may interfere with the formation of ATF7-TAF12 subcomplexes, thereby inhibiting ATF7-induced transactivation.
ATF7 and TAF12 target the genomic E-selectin promoter
To examine the TAF12-ATF7 interaction under more physiological conditions, a chromatin immunoprecipitation (ChIP) experiment was performed on the E-selectin gene where ATF7 has previously been shown to bind specifically to the NF-ELAM1 promoter element (Whelan et al., 1991; Kaszubska et al., 1993) . Raji cells, a human lymphoid cell line in which ATF7 is naturally more abundant than in other cell lines (PJH and BC, unpublished observation), were chosen for this analysis. As a first step, the cellular content of ATF7 was selectively altered, using the RNA interference (siRNA) approach. Cells were transfected with wild-type (wt) or control (mut) ATF7-specific siRNA to specifically silence the ATF7 gene. The efficiency of ATF7 knockdown was verified by Western blot (WB) analysis, showing that the ATF7 was indeed clearly decreased while TAF12 was barely affected, under the conditions used ( Figure 7a ). Having established this differential ATF7 expression system, we next applied a standard ChIP protocol (Dedon et al., 1991) . As shown in Figure 7b (compare lanes 1-4 to 5-8), antibodies against either ATF7 or TAF12 efficiently immunoprecipitated the E-selectin promoter region, only when the ATF7 content was highest. This provides strong support to the simultaneous binding of both proteins to the target promoter, in vivo. Together, these results clearly indicated that, in a natural promoter context, ATF7 is associated to essentially all of the detected TAF12 protein.
Discussion
Few examples of TAF-mediated transcriptional activation have been reported, in each case involving a specific couple of TAF and activator, such as hsTAF4-retinoic acid, thyroid hormone or vitamin D3 receptors , hsTAF7-cJun (Munz et al., 2003) , hsTAF10-estrogen receptor (Jacq et al., 1994) , hsTAF11-thyroid hormone receptor (Mengus et al., 2000) . In this study, we show that hsTAF12 potentiates ATF7 transcriptional activity, in a process that could be counterbalanced by TAF4.
Activator-specific recruitment of TFIID to the promoter of ribosomal protein coding genes has previously been documented in yeast, suggesting that direct activator-TAF interactions play important roles in response to growth stimulation (Mencia et al., 2002) . More recently, it has been concluded from a genomewide expression profiling study in yeast (Shen et al., 2003) that 84% of the genes depend upon one or more TAFs, while the remaining are TAF-independent. The authors could also assign individual TAFs to selective transcriptional functions, thus confirming and further extending the proposal that a complex combinatorial network of TFIID/SAGA components are involved in transcription activation in vivo (Bhaumik and Green, 2002) .
It has also been demonstrated that hsTAF12 heterodimerizes with hsTAF4, via HFDs similar to those of H2B and H2A, respectively . hsTAF12 can actually have alternative heterodimerization partners. Thus, within hsTFIID, hsTAF4 can be replaced by hsTAF4b, a tissue-specific hsTAF4 paralog involved in ovary development (Freiman et al., 2001) . Similarly, STAF42, a human homolog of the yeast 1 and 5) or TAF12 (lanes 2 and 6) . Endogenous E-selectin promoter DNA, coprecipitated with the indicated antibodies, was detected by PCR ATF7/TAF12 functional interaction P-J Hamard et al ADA1, was found to interact with hsTAF12, within STAGA, the human homolog of the yeast SAGA complex (Martinez et al., 2001 ). All of these complexes seem to coexist within the cell but little is known about their formation and the potential appearance of their components as free molecules in the nucleus. The global structures of both hsTFIID and yeast (y) TFIID have been resolved at low resolution by electron microscopy image analysis and the location of the yTAFs has been established (Brand et al., 1999; Leurent et al., 2002) . Considering the strong conservation between the subunits of eukaryotic TFIID complexes, it is assumed that the results obtained with yTFIID reflect the molecular organization of hsTFIID (Leurent et al., 2002) . The yeast complex is formed of three lobes, A-C, connected by linker domains. Immunolabelling experiments showed that all HFD-containing yTAFs interact pairwise (TAF3/10, TAF4/12, TAF6/9, TAF8/10, TAF11/ 13) and are each located at two distinct sites, suggesting that they may all be present at two copies. For example, the TAF4/12 tandem is found in both lobes B and C, whereas the TAF6/9 pair is located in lobes A and B (Leurent et al., 2002 (Leurent et al., , 2004 , clearly indicating that TAFs may be recruited within different molecular contexts. In the case of TAF12, we show here that an additional complex, involving ATF7, can be formed at least transiently, through yet distinct interactions. Moreover, it has been suggested that TAF1 and TAF5 play a central role in the organization of yTFIID, with TAF1 spanning lobes A and C of the complex and contacting both TAF10 and TAF12 (Leurent et al., 2004) . Together with our observation that ATF7 interacts with TAF12, this finding may explain how transcription of the cyclin A gene could be activated by ATF7 in a TAF1-dependent manner (Wang et al., 1997) .
Two hsTAF12 (12-1 and 12-2) isoforms are found in hsTFIID and STAGA complexes (Mengus et al., 1995; Martinez et al., 2001) . In all cell types examined, hsTAF12-1 was about five times more abundant than hsTAF12-2 (Perletti et al., 1999) , but their relative distribution to the different complexes is presently unknown. Interestingly, compared to other TAF transcripts, which like those of TBP are found at low levels in the cell, hsTAF12 mRNA usually accumulate to about 30-fold higher amounts (Purrello et al., 1998) . If correspondingly elevated quantities of hsTAF12 polypeptide(s) are synthesized, it is possible that besides contributing to TFIID-, STAGA-and other hsTAF12-containing complexes, they may achieve additional functions in the cell, either as free polypeptides or as subunits of other complexes.
In the present study, both TAF12 and ATF7 molecules were assayed in transfected cells, as overexpressed proteins. The cellular concentration of the other components staying unchanged, it is unlikely that the higher amounts of TAF12 produced in these cells significantly increased the level of TFIID or related complexes.
The observation that TAF4 (which binds ATF7) and TAF4b (which does not) have antagonistic effects on the TAF12-dependent activation of ATF7 (Figure 6 ) may be particularly relevant within this context. Our results raise the interesting possibility that overexpressed TAF12 titrates TAF4, a negative effector of ATF7, leaving ATF7 free to interact with the transcription machinery through the excess of TAF12. The finding that the adenovirus E1a protein is also able to bind TAF4 (Mazzarelli et al., 1997) suggests that at least part of the activity of this viral transcriptional activator involves TAF4 sequestration. Finally, it is worth mentioning that the transcriptional activity of ATF7 is systematically higher in lymphoid cell lines, compared to HeLa or Cos cells, when tested under our standard conditions. In keeping with this observation, a ChIP analysis in these cells revealed that the endogenous TAF12 protein associated to an ATF7-responsive promoter, only under conditions preserving the natural level of ATF7 protein in these cells. It is also tempting to correlate this differential activity with the exclusive expression of TAF4b in lymphoid cells and of TAF4 in HeLa or Cos cells (Dikstein et al., 1996) , and with the distinct properties of these TAFs.
While both hsTAF12 isoforms interact (mainly through their HFD) with the N-terminal activation domain of ATF7, only the N-terminal region of the largest hsTAF12 protein (hsTAF12-1) is required for the transactivation process. Interestingly, this transcriptionally active hsTAF12-1 N-terminal region shares substantial homologies with sequences of other proteins (p38, JNK) known to interact with ATF (anti D-sites). While co-IP experiments rule out any significant contribution of this conserved element to ATF binding (data not shown), we do not exclude the possibility that it is involved in contacts between hsTAF12-1 and other components of the transcription machinery, which remain to be identified.
We show that the hsTAF12-mediated activation of ATF7 depends on the integrity of two residues (M33 and L35), which are conserved in ATF2 (M51 and L53) and have been defined by sequence comparison, as part of the D-site for JNK and p38 kinases (see Chang et al., 2002; Ho et al., 2003; and Figure 5) . The presence of such a D-site on ATF7 had been postulated earlier (De Graeve et al., 1999) . Interestingly, this D-site element is located within a region originally defined as the 'activation domain', adjacent to the essential zincbinding motif (ZF, between C9 and H31) and two critical threonine residues (T51 and T53 in ATF7) (Livingstone et al., 1995; van Dam et al., 1995; De Graeve et al., 1999) . Together, these observations support an attractive model for transcriptional activation by ATF. After cell stimulation and activation of specific MAPK pathways, specific protein kinases would bind the ATF D-site, leading to the phosphorylation of T51 and T53 (in ATF7) or T69 and T71 (in ATF2) residues and to the activation of the corresponding proteins (Livingstone et al., 1995; van Dam et al., 1995; De Graeve et al., 1999) . The resulting activated form of ATF would then interact with the transcriptional machinery through hsTAF12 as an entry key.
Transient expression experiments in a p38
À/À or JNK À/À background should help in identifying the kinases ATF7/TAF12 functional interaction P-J Hamard et al involved and clarifying their roles in TAF12-dependent activation.
Materials and methods
Recombinant expression vectors
To clarify the nomenclature within the ATF transcription factor family, a new name has been recently proposed for ATFa, in accordance with the Guidelines for Human Gene Nomenclature: thus, the formerly called ATFa0, a1, a2, a3 isomers have been renamed ATF7-0, 1, 2 and 3, respectively. The recombinant isoform used in the present study is ATF7-1 and will be referred to as ATF7, with coordinates corresponding to the amino-acid numbering of the largest protein (ATF7-3, 494 residues). The pG4-ATF7-1 recombinant and the corresponding derivatives encode the DNA-binding domain of the yeast Gal4 protein fused to the wild-type (wt) or mutated human ATF7-1 polypeptide, as described (Chatton et al., 1994) . ATF7-1 cDNA and derivatives have also been inserted into the pXJ vector, under the control of the cytomegalovirus (CMV) promoter (Xiao et al., 1991) , generating the px-ATF7 series.
The pG4-ATF2 recombinant encodes the DNA-binding domain of the yeast Gal4 protein fused to the hs-ATF2 (Livingstone et al., 1995) .
The (17m5)-TK TGTA-Luc reporter (Lavigne et al., 1999) contains the luciferase gene, driven by the thymidine kinase promoter, with an altered TATA box (TGTA, only recognized by the mutant TBP, TBP-spm3 (Lavigne et al., 1999) ) and five Gal4-binding sites (see Figure 1) .
The series of hsTAF vectors encoding the human TAF II polypeptides have been described (Mengus et al., 1995; Lavigne et al., 1999; Gangloff et al., 2000) . The p-hsTAF12wt recombinant encodes both TAF12-1 and TAF12-2 proteins, through alternative initiation codon usage, whereas the deleted p-hsTAF12-2 version only encodes the shorter form. The p-hsTAF12-1was generated through oligonucleotide-directed mutagenesis by changing methionine residue 31 into isoleucine. The p-hsTAF4b vector was a gift of Richard Freiman (Freiman et al., 2001) . The pG4-cJun vector, which encodes the DNA-binding domain of the yeast Gal4 protein fused to the wild-type c-Jun protein, has been provided by Michael Karin (Derijard et al., 1994) . Point mutations and deletions were created in ATF7-1 (both in the px and pG4 series) and hsTAF12 sequences by oligonucleotide-directed mutagenesis using the Pfu-DNA polymerase (Cline et al., 1996) , PCR amplification of appropriate DNA fragments or restriction fragment deletion. All constructions were verified by DNA sequencing.
Baculoviruses expressing GST, GSTATF7, TAF12 and TAF4 were constructed as previously described (Acker et al., 1997) .
Cells, transfection, and extract preparation
Sf9 cells were grown in TNM-FH medium, infected with baculovirus-based vectors and processed as described (Acker et al., 1997) . RAJI cells were grown in RPMI medium supplemented with 10% foetal calf serum and transfected with siRNA using jetSI reagent (Polyplus Transfection, France). Cos-1 cells, grown as monolayers in Dulbecco medium supplemented with glucose (1 g/l) and 5% foetal calf serum, were transfected with recombinant plasmids, 8 h after plating, using ExGen 500 reagent (Euromedex, France) (Pollard et al., 1998) , with the amounts of recombinant DNA indicated in the figure legends. After 48 h, cells were harvested in phosphatebuffered saline (PBS) and resuspended in lysis buffer (0.4 M KCl, 20 mM Tris-HCl, pH 7.5, 20% glycerol, 5 mM dithiothreitol, 0.4 mM PMSF, 2.5 ng/ml each of leupeptin, pepstatin, aprotinin, antipain and chymostatin). After one freezethawing cycle in liquid nitrogen, the resulting crude suspension was cleared by centrifugation for 20 min at 10 000 g (Kumar and Chambon, 1988).
RNAi, ChIP and quantitative real-time PCR
Raji cells were transfected with either anti-ATF7 siRNA (ATF7-wt) or control siRNA (ATF7-mut). The sense and antisense siRNA oligonucleotides (21 nucleotides long) were synthesized and annealed, as recommended (Eurogentec, Belgium). The siRNA selected are: (sense ATF7-wt 5 0 -CUG UGA GGA AGU GGG GCU CTT-3 0 ) and (sense ATF7-mut 5 0 -CUG UGA GGA GGU GGG ACU CTT-3 0 ). At 2 days after transfection, the cells were divided in two equal fractions: (i) the first was used for preparing cellular extracts to control the amount of ATF7 and TAF12 proteins present by WB, after concentration by immunoprecipitation with specific antibodies; (ii) the second was fixed with formaldehyde (1%), before performing a ChIP assay (Dedon et al., 1991) , using a ChIP Assay Kit and following the manufacturer's recommendations (Upstate Biotechnology, USA).
Quantitative real-time PCR was performed on LightCycler (Roche Diagnostics, Switzerland) as specified by the manufacturer using FastStart DNA Master SYBR Green I reagents with 45 cycles of three-step amplification. PCR reactions were carried out with the following oligonucleotide pair, bracketing a 303 bp E-selectin promoter fragment (À227 to þ 76): 5 0 -GTC ATA TTA ATA AAA TTG CAT ATA CGA TAT-3 0 and 5 0 -TCT CAG GTG GGT ATC ACT GCT GCC TCT GTC-3 0 . After PCR, amplified DNA was collected and analysed by 1% agarose gel electrophoresis.
Antibodies
Rabbit antisera against ATF7, and monoclonal antibodies recognizing specifically the ATF7 isoforms (2F10, 1A7), GST (1D10), hsTAF12 (22TA), hsTAF4 (20TA, 32TA) and HA epitope (12CA5) have been described (Mengus et al., 1995; Bocco et al., 1996) . Rabbit antiserum against hsTAF12 is a gift of Thomas Oegelschla¨ger.
IP and immunoblotting
After a preliminary clearing step on protein A-Sepharose to adsorb nonspecific binding proteins, aliquots of the cell extracts were incubated (3 h at 41C) with 50 ml of a 50% protein G-Sepharose bead suspension in PBS, along with the antibody. The beads were washed three times with 1 ml of PBS, 0.5% Nonidet P-40 and NaCl adjusted to 250 mM. The proteins were then dissociated by boiling for 5 min in 20 ml sample buffer, before SDS-10% PAGE (SDS-PAGE). Protein analysis by WB was carried out as described (Bocco et al., 1996) . Briefly, proteins were electrotransferred onto nitrocellulose, reacted with specific primary antibodies (see above) and revealed with peroxidase-linked goat anti-mouse k-light chain or goat anti-rabbit immunoglobulins (Santa-Cruz) as indicated, using the ECL system (Amersham).
Baculovirus infection and GST-pulldown assay
Sf9 cells were coinfected for 48 h with recombinant viruses expressing hsTAF with either the GST unfused or GST-fused ATF7 protein. After a preliminary clearing step on protein ASepharose to adsorb nonspecific binding proteins, extracts were incubated with glutathione (GSH)-Sepharose beads for 2 h at 41C. Then, the beads were washed with PBS buffer containing 0.5% Nonidet P-40 and NaCl adjusted to 250 mM to minimize nonspecific interactions. Retained proteins were analysed by SDS-PAGE and visualized by WB using specific antibodies.
Luciferase assay
Transfected cells were harvested, in ice-cold PBS, pelleted, washed once in PBS and resuspended in lysis buffer (100 mM potassium phosphate, pH 7.8). After three freeze-thawing steps in liquid nitrogen, the resulting cell lysate was cleared by centrifugation. Aliquots of the extracts (normalized by protein concentration) were assayed for luciferase activity using a Berthold 'Centro LB 960' luminometer, as previously described (de Wet et al., 1987; Steghens et al., 1998) . In all cases, at least five independent transfections were carried out and the results always agreed within 10%. The results of typical experiments are shown in the figures.
Abbreviations ATF, activating transcription factor; TBP, TATA-binding protein; TAF, TBP-associated factor; HFD, histone fold domain; TFIID, transcription factor IID; IP, immunoprecipitation; MAP kinase, mitogen-activated protein kinase; JNK, Jun N-terminal kinase; CREB, cyclic AMP responsive binding protein; b-LZ, basic region leucine zipper; CRE, cyclic AMP responsive binding; SAGA, SPT-ADA-GCN5-acetyltransferase; STAGA, SPT3-TAF9-GCN5-L acetyltransferase; PCAF, p300/ CREB-binding protein-associated factor; TFTC, TBP-free TAF-containing complex; CMV, cytomegalovirus; TK, thymidine kinase; GST, glutathione S-transferase; HA, hemaglutinin; WB, Western blot; ChIP, chromatin-immunoprecipitation.
